CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Innovative Pharmaceutical Biotech Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Innovative Pharmaceutical Biotech Ltd
Room 2111, West Tower, Shun Tak Centre
168-200 Connaught Road
Phone: +852 25986818p:+852 25986818 Hong Kong Ticker: 399399
Business Summary
Innovative Pharmaceutical Biotech Limited is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The Company operates through five segments. Genetic Testing Services segment is engaged in the provision of genetic testing services in the People’s Republic of China (PRC) and Hong Kong. Bio-Industrial Products segment is engaged in the distribution of bio-industrial products in the PRC. Beauty Equipment and Products segment is engaged in the trading of beauty equipment and products in Hong Kong. Securities Investment segment is engaged in securities investment in Hong Kong and outside Hong Kong. Research and Development segment is engaged in the research, development and commercialization of the oral insulin products.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20243/31/2024YesYes---

Industries
SIC Code Description
5087 Service establishment equipment and supplies
5122 Drugs, drug proprietaries, and druggists' sundries
8731 Commercial physical and biological research
6211 Security brokers, dealers, and flotation companies
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
2835 In vitro and in vivo diagnostic substances
5047 Medical, dental, and hospital equipment and supplies
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Non-Executive Director NianJiang 68 6/10/2011 12/21/2010
Financial Controller, Company Secretary Hon YinPoon 56 5/14/2013 5/14/2013
Executive Director Tak YiuCheng 48 7/4/2023 7/4/2023
7 additional Officers and Directors records available in full report.

Business Names
Business Name
399
FEPTY

General Information
Number of Employees: 20 (As of 3/31/2024)
Outstanding Shares: 1,822,202,924 (As of 9/10/2024)
Stock Exchange: HKG
Fax Number: +852 25986628


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024